TRPV4基因变异引起先天性骨病遗传学分析
收稿日期: 2022-11-15
网络出版日期: 2023-07-05
基金资助
国家自然科学基金项目(32270728)
Genetic characteristics of TRPV4-related congenital skeletal disorder
Received date: 2022-11-15
Online published: 2023-07-05
目的 对4例不同严重程度的先天性骨病患儿进行基因诊断以明确其遗传学病因。总结临床特点并进行基因型-表型分析。方法 收集4例患儿的临床资料,采集患儿及父母外周血并提取DNA,患儿行全外显子组测序,根据ACMG遗传变异分类标准与指南判断变异位点致病性,对患儿及父母进行Sanger测序验证。结果 4例患儿均携带TRPV4基因杂合变异,其中2个错义变异遗传自患病父母,1个缺失插入变异和1个错义变异为新生变异,分别为c.2077G>A (p.Val693Met),c.1199G>A (p.Arg400Gln),c.1657delinsACTA (p.Tyr553delinsThrAsn),和c.259G>A (p.Glu87Lys),以上位点国内外未见报道。1-3号患儿有不同程度的身材矮小,4例患儿均有先天性脊柱侧弯及其他骨骼系统异常。分别诊断为轻型变形性骨发育不良、3型常染色体显性短躯干、变形性骨发育不良合并类扭伤型侏儒及经典型变形性骨发育不良。携带相同变异的患儿父亲/母亲有轻度的骨骼畸形。结论 TRPV4基因不同位点变异引起的先天性骨病表型互有重叠但严重程度差异较大,可根据分子诊断结果进行鉴别诊断及临床干预。
张文妍 , 姚子明 , 张学军 , 张耀东 , 王凌飞 , 胡旭昀 , 郝婵娟 . TRPV4基因变异引起先天性骨病遗传学分析[J]. 临床儿科杂志, 2023 , 41(7) : 530 -536 . DOI: 10.12372/jcp.2023.22e1509
Objective To identify the genetic causes of four patients with different severity of congenital skeletal disorder by genetic diagnosis, and to summarize the clinical characteristics and analyze the genotype-phenotype. Methods The clinical data of four patients were collected. The peripheral blood of the patients and their parents were collected and DNA was extracted. Whole exome sequencing of patients was performed and variants were classified following the interpretation standards and guidelines of the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology. Putative pathogenic variants were verified by Sanger sequencing. Results The four patients all carried TRPV4 heterozygous variants. Two missense variants were inherited from affected parents, and one deletion insertion variant and missense variant were de novo: c.2077G>A (p.Val693Met), c.1199G>A (p.Arg400Gln), c.1657delinsACTA (p.Tyr553delinsThrAsn) and c.259G>A (p.Glu87Lys). None of these variants have been previously reported. Patients 1-3 had varying degrees of short stature, and all 4 had congenital scoliosis and other skeletal deformities. They were diagnosed as mild Metatropic Dysplasia, Autosomal Dominant Brachyomia type 3, Parastremmatic Dysplasia with Metatropic Dysplasia, and classic Metatropic Dysplasia respectively. Their parents with the same variant also had mild bone deformity. Conclusions The phenotypes of congenital skeletal disorders caused by different variants in TRPV4 gene were widely heterogeneous. Patients often present with overlapping skeletal system abnormalities. Therefore, differential diagnosis and clinical intervention can be conducted according to the molecular diagnosis results.
| [1] | Mortier GR, Cohn DH, Cormier-Daire V, et al. Nosology and classification of genetic skeletal disorders: 2019 revision[J]. Am J Med Genet A, 2019, 179(12): 2393-2419. |
| [2] | ürel-Demir G, ?im?ek-Kiper P?, ?ncel ?, et al. Natural history of TRPV4-related disorders: from skeletal dysplasia to neuromuscular phenotype[J]. Eur J Paediatr Neurol, 2021, 32: 46-55. |
| [3] | Nishimura G, Lausch E, Savarirayan R, et al. TRPV4-associated skeletal dysplasias[J]. Am J Med Genet C Semin Med Genet, 2012, 160C(3): 190-204. |
| [4] | Geneviève D, Le Merrer M, Feingold J, et al. Revisiting metatropic dysplasia: presentation of a series of 19 novel patients and review of the literature[J]. Am J Med Genet A, 2008, 146A(8): 992-996. |
| [5] | Krakow D, Vriens J, Camacho N, et al. Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia[J]. Am J Hum Genet, 2009, 84(3): 307-315. |
| [6] | Rock MJ, Prenen J, Funari VA, et al. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia[J]. Nat Genet, 2008, 40(8): 999-1003. |
| [7] | Nishimura G, Dai J, Lausch E, et al. Spondylo-epiphyseal dysplasia, Maroteaux type (pseudo-Morquio syndrome type 2), and parastremmatic dysplasia are caused by TRPV4 mutations[J]. Am J Med Genet A, 2010, 152A(6): 1443-1449. |
| [8] | Lamandé SR, Yuan Y, Gresshoff IL, et al. Mutations in TRPV4 cause an inherited arthropathy of hands and feet[J]. Nat Genet, 2011, 43(11): 1142-1146. |
| [9] | White JP, Cibelli M, Urban L, et al. TRPV4: molecular conductor of a diverse orchestra[J]. Physiol Rev, 2016, 96(3): 911-973. |
| [10] | Everaerts W, Nilius B, Owsianik G. The vanilloid transient receptor potential channel TRPV4: from structure to disease[J]. Prog Biophys Mol Biol, 2010, 103(1): 2-17. |
| [11] | Arniges M, Fernández-Fernández JM, Albrecht N, et al. Human TRPV4 channel splice variants revealed a key role of ankyrin domains in multimerization and trafficking[J]. J Biol Chem, 2006, 281(3): 1580-1586. |
| [12] | Deng Z, Paknejad N, Maksaev G, et al. Cryo-EM and X-ray structures of TRPV4 reveal insight into ion permeation and gating mechanisms[J]. Nat Struct Mol Biol, 2018, 25(3): 252-260. |
| [13] | Loukin SH, Teng J, Kung C. A channelopathy mechanism revealed by direct calmodulin activation of TrpV4[J]. Proc Natl Acad Sci U S A, 2015, 112(30): 9400-9405. |
| [14] | Strotmann R, Schultz G, Plant TD. Ca2+-dependent potentiation of the nonselective cation channel TRPV4 is mediated by a C-terminal calmodulin binding site[J]. J Biol Chem, 2003, 278(29): 26541-26549. |
| [15] | Ji C, McCulloch CA. TRPV4 integrates matrix mecha-nosensing with Ca2+ signaling to regulate extracellular matrix remodeling[J]. FEBS J, 2021, 288(20): 5867-5887. |
| [16] | Toft-Bertelsen TL, MacAulay N. TRPing to the point of clarity: understanding the function of the complex TRPV4 ion channel[J]. Cells, 2021, 10(1): 165. |
| [17] | Camacho N, Krakow D, Johnykutty S, et al. Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia[J]. Am J Med Genet A, 2010, 152A(5): 1169-1177. |
| [18] | Dicks AR, Maksaev GI, Harissa Z, et al. Skeletal dysplasia-causing TRPV4 mutations suppress the hypertrophic differentiation of human iPSC-derived chondrocytes[J]. Elife, 2023, 12: e71154. |
| [19] | Hou W, Fu H, Liu X, et al. Cation channel transient receptor potential vanilloid 4 mediates topography-induced osteoblastic differentiation of bone marrow stem cells[J]. ACS Biomater Sci Eng, 2019, 5(12): 6520-6529. |
| [20] | Clark AL, Votta BJ, Kumar S, et al. Chondroprotective role of the osmotically sensitive ion channel transient receptor potential vanilloid 4: age- and sex-dependent progression of osteoarthritis in Trpv4-deficient mice[J]. Arthritis Rheum, 2010, 62(10): 2973-2983. |
| [21] | Willard VP, Leddy HA, Palmer D, et al. Transient receptor potential vanilloid 4 as a regulator of induced pluripotent stem cell chondrogenesis[J]. Stem Cells, 2021, 39(11): 1447-1456. |
| [22] | Rorden C, Griswold MC, Moses N, et al. Radiographical survey of osteochondrodysplasia in Scottish Fold cats caused by the TRPV4 gene variant[J]. Hum Genet, 2021, 140(11): 1525-1534. |
| [23] | Ji C, Mcculloch CA. TRPV4 integrates matrix mechanosensing with Ca2+ signaling to regulate extracellular matrix remodeling[J]. FEBS J, 2021, 288(20): 5867-5887. |
| [24] | Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. |
| [25] | Nishimura G, Kizu R, Kijima Y, et al. Spondyloepiphyseal dysplasia Maroteaux type: report of three patients from two families and exclusion of type II collagen defects[J]. Am J Med Genet A, 2003, 120A(4): 498-502. |
| [26] | Nemec SF, Cohn DH, Krakow D, et al. The importance of conventional radiography in the mutational analysis of skeletal dysplasias (the TRPV4 mutational family)[J]. Pediatr Radiol, 2012, 42(1): 15-23. |
| [27] | Kozlowski K. La dysostose spondylometaphysaire[M]. Presse Méd., 1967, 75: 2769-2774. |
| [28] | Poznanski AK. Progress in pediatric radiology[M]. Vol. 4: Intrinsic Diseases of Bones:The Radiological Society of North America, 1973. |
| [29] | Kannu P, Aftimos S, Mayne V, et al. Metatropic dysplasia: clinical and radiographic findings in 11 patients demonstrating long-term natural history[J]. Am J Med Genet A, 2007, 143A(21): 2512-2522. |
| [30] | Geneviève D, Le Merrer M, Munnich A, et al. Long-term follow-up in a patient with metatropic dysplasia[J]. Am J Med Genet A, 2005, 135(3): 342-343. |
| [31] | Vriens J, Owsianik G, Janssens A, et al. Determinants of 4 alpha-phorbol sensitivity in transmembrane domains 3 and 4 of the cation channel TRPV4[J]. J Biol Chem, 2007, 282(17): 12796-12803. |
| [32] | Klausen TK, Pagani A, Minassi A, et al. Modulation of the transient receptor potential vanilloid channel TRPV4 by 4alpha-phorbol esters: a structure-activity study[J]. J Med Chem, 2009, 52(9): 2933-2939. |
| [33] | McCray BA, Schindler A, Hoover-Fong JE, et al. Autosomal dominant TRPV4 disorders[DB/OL]. GeneReviews? [Internet]: University of Washington, Seattle, 2020. |
| [34] | 袁佳雨, 孙东兰, 李亚洲. TRPV4基因的两个不同变异导致变形性骨发育不良表型严重程度差异[J]. 中国组织化学与细胞化学杂志, 2021, 30(6): 545-551. |
/
| 〈 |
|
〉 |